| Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer A de Gramont, A Figer, M Seymour, M Homerin, A Hmissi, J Cassidy, ... Journal of clinical oncology 18 (16), 2938-2947, 2000 | 5061 | 2000 |
| Niraparib in patients with newly diagnosed advanced ovarian cancer A González-Martín, B Pothuri, I Vergote, R DePont Christensen, ... New England Journal of Medicine 381 (25), 2391-2402, 2019 | 1698 | 2019 |
| Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor–positive, human epidermal growth factor receptor 2–negative metastatic … T Bachelot, C Bourgier, C Cropet, I Ray-Coquard, JM Ferrero, G Freyer, ... Journal of Clinical Oncology 30 (22), 2718-2724, 2012 | 875 | 2012 |
| Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis … O Glehen, D Osinsky, E Cotte, F Kwiatkowski, G Freyer, S Isaac, ... Annals of Surgical Oncology 10, 863-869, 2003 | 437 | 2003 |
| Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study O Glehen, F Mithieux, D Osinsky, AC Beaujard, G Freyer, PH Guertsch, ... Journal of Clinical Oncology 21 (5), 799-806, 2003 | 330 | 2003 |
| Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer O Glehen, V Schreiber, E Cotte, AC Sayag-Beaujard, D Osinsky, G Freyer, ... Archives of surgery 139 (1), 20-26, 2004 | 305 | 2004 |
| Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0–04 phase II trial JP Gérard, O Chapet, C Nemoz, P Romestaing, F Mornex, R Coquard, ... Journal of clinical oncology 21 (6), 1119-1124, 2003 | 264 | 2003 |
| Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. JY Blay, F Chauvin, A Le Cesne, B Anglaret, D Bouhour, C Lasset, ... Journal of Clinical Oncology 14 (2), 636-643, 1996 | 214 | 1996 |
| Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy. G Freyer, T Delozier, M Lichinister, D Gedouin, P Bougnoux, P His, ... Journal of Clinical Oncology: Official Journal of the American Society of …, 2003 | 173 | 2003 |
| Biology of cancer and aging: a complex association with cellular senescence C Falandry, M Bonnefoy, G Freyer, E Gilson Journal of Clinical Oncology 32 (24), 2604-2610, 2014 | 165 | 2014 |
| Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs F Ranchon, G Salles, HM Späth, V Schwiertz, N Vantard, S Parat, ... BMC cancer 11, 1-10, 2011 | 161 | 2011 |
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 … N Bakrin, E Cotte, F Golfier, FN Gilly, G Freyer, W Helm, O Glehen, ... Annals of surgical oncology 19, 4052-4058, 2012 | 149 | 2012 |
| Addition of Oxaliplatin to Continuous Fluorouracil, l-Folinic Acid, and Concomitant Radiotherapy in Rectal Cancer: The Lyon R 97-03 Phase I Trial G Freyer, N Bossard, P Romestaing, F Mornex, O Chapet, V Trillet-Lenoir, ... Journal of clinical oncology 19 (9), 2433-2438, 2001 | 135 | 2001 |
| Quantitative prognostic indices in peritoneal carcinomatosis FN Gilly, E Cotte, C Brigand, O Monneuse, AC Beaujard, G Freyer, ... European Journal of Surgical Oncology (EJSO) 32 (6), 597-601, 2006 | 133 | 2006 |
| 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ... The Lancet 393 (10191), 2591-2598, 2019 | 131 | 2019 |
| Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result V Bonadona, P Saltel, F Desseigne, H Mignotte, JC Saurin, Q Wang, ... Cancer Epidemiology Biomarkers & Prevention 11 (1), 97-104, 2002 | 129 | 2002 |
| Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial C Falandry, B Weber, AM Savoye, F Tinquaut, O Tredan, E Sevin, ... Annals of oncology 24 (11), 2808-2813, 2013 | 118 | 2013 |
| First-line therapy in ovarian cancer trials T Thigpen, J McAlpine, P DiSaia, K Fujiwara, W Hoskins, G Kristensen, ... International Journal of Gynecologic Cancer 21 (4), 2011 | 117 | 2011 |
| A randomized trial of leucovorin (LV) and 5-fluorouracil (5FU) with or without oxaliplatin in advanced colorectal cancer (CRC) A De Gramont, A Figer, M Seymour, M Homerin, N Le Bail, J Cassidy, ... Proc Am Soc Clin Oncol 17, 257a, 1998 | 117 | 1998 |
| Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy … G Freyer, P Rougier, R Bugat, JP Droz, M Marty, H Bleiberg, D Mignard, ... British journal of cancer 83 (4), 431-437, 2000 | 102 | 2000 |
